Cancer gene therapy requires introducing new genetic material into target cells through an effective vector without toxicity to non-target tissues. Adenoviral vectors are good candidates for direct in vivo gene transfer. The world's first licensed gene therapy product is based on the adenovirus as a gene delivery vector. Creative Biolabs provides the state-of-the-art adenoviral vector with the various design and construction to meet the demand in basic research and preclinical applications. human adenovirus vector https://www.creative-biolabs.com/gene-therapy/adenovirus-vector.htm